Paper42903495PubMed
Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study.
Hastings WJ and 4 others. Plast Reconstr Surg Glob Open, 2026.
Cite this record
ConductScience Library. Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study. Papers, record 42903495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903495
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study.
- Journal
- Plast Reconstr Surg Glob Open
- Year
- 2026
- Publication types
- Case Reports, Journal Article
- Revised in PubMed
- 2026-10-23
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19903300 | Human skin wounds: a major and snowballing threat to public health and the economy. | Wound Repair Regen | 2009 | https://conductscience.org/library/papers/19903300 | PubMed |
| 2 | 37424179 | NAD metabolism: Role in senescence regulation and aging. | Aging Cell | 2024 | https://conductscience.org/library/papers/37424179 | PubMed |
| 3 | 34936607 | Complications in Brachioplasty: A Systematic Review and Meta-Analysis. | Plast Reconstr Surg | 2022 | https://conductscience.org/library/papers/34936607 | PubMed |
| 4 | 42530810 | Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. | Geroscience | 2026 | https://conductscience.org/library/papers/42530810 | PubMed |
| 5 | 18387479 | Scar treatments: preclinical and clinical studies. | J Am Coll Surg | 2008 | https://conductscience.org/library/papers/18387479 | PubMed |
| 6 | 36716673 | SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc. | Redox Biol | 2023 | https://conductscience.org/library/papers/36716673 | PubMed |
| 7 | 38057866 | Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis. | J Transl Med | 2023 | https://conductscience.org/library/papers/38057866 | PubMed |
| 8 | 29074993 | Epidermal SIRT1 regulates inflammation, cell migration, and wound healing. | Sci Rep | 2017 | https://conductscience.org/library/papers/29074993 | PubMed |
| 9 | 20566667 | The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. | Diabetes | 2010 | https://conductscience.org/library/papers/20566667 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42903495
GET https://conductscience.org/api/papers/v1/42903495/authors